Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maingon

Showing results (321-330 of 340) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2018
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized TrialYungan Tao, Anne Auperin, Christian Sire, et al.
The Lancet. Oncology|January 21, 2012
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trialJean Bourhis, Christian Sire, Pierre Graff, et al.
Gastroenterologie Clinique Et Biologique|July 23, 1999
[What can be done for digestive cancer in 1999? Recommendations of the French Foundation of Digestive Cancer (1st Part)]J C Barbare, L Bedenne, O Bouché, et al.
Gastroenterologie Clinique Et Biologique|August 3, 1999
[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)]J C Barbare, L Bedenne, O Bouché, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2021
Current practice in proton therapy delivery in adult cancer patients across EuropeMakbule Tambas, Hans Paul van der Laan, Roel J H M Steenbakkers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasetsTomas Skripcak, Claus Belka, Walter Bosch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2012
Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCEJ Thariat, T Schouman, A Brouchet, et al.
European Urology|November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.
The Lancet. Oncology|August 1, 2017
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysisBenjamin Lacas, Jean Bourhis, Jens Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2017
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelinesVincent Grégoire, Mererid Evans, Quynh-Thu Le, et al.
Pageof 34

Showing results (321-330 of 340) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2018
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized TrialYungan Tao, Anne Auperin, Christian Sire, et al.
The Lancet. Oncology|January 21, 2012
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trialJean Bourhis, Christian Sire, Pierre Graff, et al.
Gastroenterologie Clinique Et Biologique|July 23, 1999
[What can be done for digestive cancer in 1999? Recommendations of the French Foundation of Digestive Cancer (1st Part)]J C Barbare, L Bedenne, O Bouché, et al.
Gastroenterologie Clinique Et Biologique|August 3, 1999
[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)]J C Barbare, L Bedenne, O Bouché, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2021
Current practice in proton therapy delivery in adult cancer patients across EuropeMakbule Tambas, Hans Paul van der Laan, Roel J H M Steenbakkers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasetsTomas Skripcak, Claus Belka, Walter Bosch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2012
Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCEJ Thariat, T Schouman, A Brouchet, et al.
European Urology|November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.
The Lancet. Oncology|August 1, 2017
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysisBenjamin Lacas, Jean Bourhis, Jens Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2017
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelinesVincent Grégoire, Mererid Evans, Quynh-Thu Le, et al.
Pageof 34